Clinical • Enrollment change • Trial primary completion date • IO biomarker
|
ALB (Albumin)
|
BRAF V600E • BRAF V600 • BRAF V600K
|
Opdivo (nivolumab) • Mekinist (trametinib) • Yervoy (ipilimumab) • Tafinlar (dabrafenib) • CS1002 (ipilimumab biosimilar)